These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30649377)

  • 61. The prognostic value of pathologic prostate-specific antigen mass ratio in patients with localized prostate cancer with negative surgical resection margins.
    Lee S; Jeong CW; Jeong SJ; Hong SK; Choi W; Byun SS; Lee SE
    Urology; 2013 Oct; 82(4):865-9. PubMed ID: 23830078
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Early oncological outcomes of robot-assisted radical prostatectomy for high-grade prostate cancer.
    Wambi CO; Siddiqui SA; Krane LS; Agarwal PK; Stricker HJ; Peabody JO
    BJU Int; 2010 Dec; 106(11):1739-45. PubMed ID: 20575980
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Localized prostate cancer and robot-assisted laparoscopic radical prostatectomy: a retrospective, comparative study between pre- and post-operative Gleason scores.
    Henderickx MMEL; Brits T; Muilwijk T; Adams T; Vandeursen H
    Acta Chir Belg; 2018 Feb; 118(1):15-20. PubMed ID: 28720050
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model.
    Lucca I; Shariat SF; Briganti A; Lotan Y; Roehrborn CG; Montorsi F; Remzi M; Seitz C; Fajkovic H; Klingler C; Karakiewicz PI; Sun M; Rouprêt M; Loidl W; Pummer K; Klatte T
    Urol Oncol; 2015 Feb; 33(2):71.e21-6. PubMed ID: 25443275
    [TBL] [Abstract][Full Text] [Related]  

  • 65. No clinical significance of the time interval between biopsy and robotic-assisted radical prostatectomy for patients with clinically localized prostate cancer on biochemical recurrence: a propensity score matching analysis.
    Hirasawa Y; Ohori M; Sugihara T; Hashimoto T; Satake N; Gondo T; Nakagami Y; Namiki K; Yoshioka K; Nakashima J; Tachibana M; Ohno Y
    Jpn J Clin Oncol; 2017 Nov; 47(11):1083-1089. PubMed ID: 28973504
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
    Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
    Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlation between the preoperative serum prostate specific antigen, Gleason score, and clinical staging with pathological outcome following robot-assisted radical prostatectomy: an Indian experience.
    Singh P; Dogra PN; Gupta NP; Nayyar R; Seth A; Javali TD; Kumar R
    Indian J Cancer; 2011; 48(4):483-7. PubMed ID: 22293265
    [TBL] [Abstract][Full Text] [Related]  

  • 68. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
    Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
    Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Significance of Gleason Score 7 With Tertiary Pattern 5 at Radical Prostatectomy.
    Borhan W; Epstein JI
    Urology; 2017 Feb; 100():175-179. PubMed ID: 27810358
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The prognostic impact of downgrading and upgrading from biopsy to radical prostatectomy among men with Gleason score 7 prostate cancer.
    Jang WS; Koh DH; Kim J; Lee JS; Chung DY; Ham WS; Rha KH; Choi YD
    Prostate; 2019 Dec; 79(16):1805-1810. PubMed ID: 31483062
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001.
    Sengupta S; Slezak JM; Blute ML; Leibovich BC; Sebo TJ; Myers RP; Cheville JC; Bergstralh EJ; Zincke H
    Cancer; 2006 Jun; 106(12):2630-5. PubMed ID: 16703592
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pathologic findings in patients who underwent robot-assisted radical prostatectomy following active surveillance: a prospective study in a single center.
    Ha YS; Yu J; Patel N; Hassanzadeh Salmasi A; Parihar J; Kwon TG; Kim WJ; Kim IY
    Minerva Urol Nefrol; 2015 Mar; 67(1):1-9. PubMed ID: 25664959
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of positive surgical margin status in predicting early biochemical recurrence after robot-assisted radical prostatectomy.
    Morizane S; Yumioka T; Makishima K; Tsounapi P; Iwamoto H; Hikita K; Honda M; Umekita Y; Takenaka A
    Int J Clin Oncol; 2021 Oct; 26(10):1961-1967. PubMed ID: 34313905
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [SIGNIFICANCE OF INTRADUCTAL CARCINOMA OF THE PROSTATE IN POST-OPERATIVE BIOCHEMICAL RECURRENCE].
    Sakamoto N; Ueda S; Mizoguchi H; Kawahara I; Kobayashi T; Hamaguchi M; Yoshikawa M
    Nihon Hinyokika Gakkai Zasshi; 2017; 108(1):5-11. PubMed ID: 29367511
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical significance and risk factors of International Society of Urological Pathology (ISUP) grade upgrading in prostate cancer patients undergoing robot-assisted radical prostatectomy.
    Takeshima Y; Yamada Y; Teshima T; Fujimura T; Kakutani S; Hakozaki Y; Kimura N; Akiyama Y; Sato Y; Kawai T; Yamada D; Kume H
    BMC Cancer; 2021 May; 21(1):501. PubMed ID: 33947348
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence.
    Sim HG; Telesca D; Culp SH; Ellis WJ; Lange PH; True LD; Lin DW
    J Urol; 2008 May; 179(5):1775-9. PubMed ID: 18343432
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Should we replace the Gleason score with the amount of high-grade prostate cancer?
    Vis AN; Roemeling S; Kranse R; Schröder FH; van der Kwast TH
    Eur Urol; 2007 Apr; 51(4):931-9. PubMed ID: 16935413
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Downgrading of biopsy based Gleason score in prostatectomy specimens.
    Treurniet KM; Trudel D; Sykes J; Evans AJ; Finelli A; Van der Kwast TH
    J Clin Pathol; 2014 Apr; 67(4):313-8. PubMed ID: 24403214
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Does a tertiary Gleason pattern 4 or 5 influence the risk of biochemical relapse after radical prostatectomy for clinically localized prostate cancer?
    Servoll E; Saeter T; Vlatkovic L; Nesland J; Waaler G; Beisland HO
    Scand J Urol Nephrol; 2010 Sep; 44(4):217-22. PubMed ID: 20367396
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The factors predicting biochemical recurrence in patients with radical prostatectomy.
    Koca O; Ün S; Türk H; Zorlu F
    Arch Ital Urol Androl; 2016 Jan; 87(4):270-5. PubMed ID: 26766796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.